Drug & intervention

Gilenya

RxCUI 1012896

Clinical trials3

Recruiting0

Related conditions3

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

3 shown

Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya.NCT02225977 · 2013-07-31

Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MSNCT02048072 · 2013-07-01

Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With GilenyaNCT02137707 · 2012-11-01

Conditions being studied

Multiple Sclerosis2 Autonomic Nervous System Dysfunction1 Multiple Sclerosis-Relapsing-Remitting1

Research locations

HalifaxNova Scotia, Canada1 Los AngelesCalifornia, United States1 MontrealQuebec, Canada1 OttawaOntario, Canada1 VancouverBritish Columbia, Canada1

Leading sponsors

Jochen Vehoff1 McGill University1 University of Southern California1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.